Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer.
Looking at options history for Pfizer (NYSE:PFE) we detected 18 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $635,420 and 15, calls, for a total amount of $588,190.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $25.0 and $31.0 for Pfizer, spanning the last three months.
Insights into Volume & Open Interest
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Pfizer's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Pfizer's significant trades, within a strike price range of $25.0 to $31.0, over the past month.
Pfizer Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
PFE | PUT | SWEEP | BEARISH | 01/17/25 | $0.69 | $0.61 | $0.66 | $25.00 | $327.5K | 58.9K | 5.0K |
PFE | PUT | TRADE | BULLISH | 06/07/24 | $0.19 | $0.18 | $0.18 | $28.00 | $241.9K | 1.6K | 14.4K |
PFE | CALL | SWEEP | BULLISH | 06/07/24 | $0.3 | $0.29 | $0.3 | $30.00 | $95.5K | 2.4K | 6.7K |
PFE | PUT | SWEEP | BEARISH | 01/17/25 | $0.66 | $0.62 | $0.66 | $25.00 | $66.0K | 58.9K | 7.0K |
PFE | CALL | SWEEP | BULLISH | 06/07/24 | $0.19 | $0.17 | $0.18 | $30.00 | $56.4K | 2.4K | 3.2K |
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Following our analysis of the options activities associated with Pfizer, we pivot to a closer look at the company's own performance.
Pfizer's Current Market Status
With a trading volume of 17,877,955, the price of PFE is up by 2.47%, reaching $29.27.
Current RSI values indicate that the stock is may be overbought.
Next earnings report is scheduled for 69 days from now.
Expert Opinions on Pfizer
In the last month, 2 experts released ratings on this stock with an average target price of $32.5.
An analyst from BMO Capital has revised its rating downward to Outperform, adjusting the price target to $36.
Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Pfizer with a target price of $29.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Pfizer with Benzinga Pro for real-time alerts.
有大量资金可以花的大户对辉瑞采取了明显的看涨立场。
查看辉瑞(纽约证券交易所代码:PFE)的期权历史记录,我们发现了18笔交易。
如果我们考虑每笔交易的具体情况,可以准确地说,55%的投资者以看涨的预期开仓,44%的投资者以看跌的预期开盘。
在已发现的全部交易中,有3笔是看跌期权,总额为635,420美元,15笔是看涨期权,总额为588,190美元。
预期的价格走势
在评估了交易量和未平仓合约之后,很明显,主要市场走势者将注意力集中在辉瑞过去三个月的25.0美元至31.0美元之间的价格区间上。
对交易量和未平仓合约的见解
检查交易量和未平仓合约为股票研究提供了至关重要的见解。这些信息是衡量辉瑞期权在特定行使价下的流动性和利息水平的关键。下面,我们简要介绍了过去一个月辉瑞重大交易的看涨期权和未平仓合约的趋势,行使价区间为25.0美元至31.0美元。
辉瑞看涨期权和看跌期权交易量:30天概述
值得注意的期权活动:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
PFE | PUT | SWEEP | BEARISH | 01/17/25 | $0.69 | $0.61 | $0.66 | $25.00 | $327.5K | 58.9K | 5.0K |
PFE | PUT | TRADE | BULLISH | 06/07/24 | $0.19 | $0.18 | $0.18 | $28.00 | $241.9K | 1.6K | 14.4K |
PFE | CALL | SWEEP | BULLISH | 06/07/24 | $0.3 | $0.29 | $0.3 | $30.00 | $95.5K | 2.4K | 6.7K |
PFE | PUT | SWEEP | BEARISH | 01/17/25 | $0.66 | $0.62 | $0.66 | $25.00 | $66.0K | 58.9K | 7.0K |
PFE | CALL | SWEEP | BULLISH | 06/07/24 | $0.19 | $0.17 | $0.18 | $30.00 | $56.4K | 2.4K | 3.2K |
关于辉瑞
辉瑞是全球最大的制药公司之一,年销售额接近 500 亿美元(不包括 COVID-19 产品的销售额)。尽管它历来销售许多类型的医疗保健产品和化学品,但现在处方药和疫苗占销售额的大部分。最畅销的产品包括肺炎球菌疫苗Prevnar 13、抗癌药物Ibrance和心血管治疗药物Eliquis。辉瑞在全球销售这些产品,国际销售额占总销售额的近50%。在国际销售中,新兴市场是主要贡献者。
在我们分析了与辉瑞相关的期权活动之后,我们将着手仔细研究公司自身的业绩。
辉瑞目前的市场地位
关于辉瑞的专家意见
上个月,2位专家发布了该股的评级,平均目标价为32.5美元。
交易期权涉及更大的风险,但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略贸易调整、利用各种指标以及随时关注市场动态来降低这些风险。使用Benzinga Pro了解辉瑞的最新期权交易,以获取实时警报。